IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.

Future oncology (London, England)

Volumn 9, Issue 12, 2013, Pages 1923-1935

  Krell, Daniel ^a   Mulholland, Paul ^b   Frampton, Adam E ^b   Krell, Jonathan ^b   Stebbing, Justin ^b   Bardella, Chiara ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2, HUMAN; TUMOR MARKER;

CARCINOGENESIS; GENETICS; HUMAN; MOLECULARLY TARGETED THERAPY; MUTATION; NEOPLASM; OXIDATIVE STRESS; PATHOLOGY; PROGNOSIS; REVIEW;

CARCINOGENESIS; HUMANS; ISOCITRATE DEHYDROGENASE; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASMS; OXIDATIVE STRESS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898010901     PISSN: None     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.143     Document Type: Review

References (0)